Cooling and immunomodulation for treating hypoxic‐ischemic brain injury
Autor: | Justin M. Dean, Joanne O. Davidson, Alistair J. Gunn, Kenta H T Cho, Laura Bennet |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_treatment
Encephalopathy Anti-Inflammatory Agents Hypoxic ischemic brain injury Inflammation 030204 cardiovascular system & hematology Cell Maturation Bioinformatics Neuroprotection Immunomodulation Pathogenesis 03 medical and health sciences 0302 clinical medicine Hypothermia Induced 030225 pediatrics medicine Animals Humans Immunologic Factors business.industry Stem Cells Infant Newborn Stem-cell therapy Hypothermia medicine.disease Combined Modality Therapy Cold Temperature Brain Injuries Hypoxia-Ischemia Brain Pediatrics Perinatology and Child Health medicine.symptom business |
Zdroj: | Pediatrics International. 62:770-778 |
ISSN: | 1442-200X 1328-8067 |
DOI: | 10.1111/ped.14215 |
Popis: | Therapeutic hypothermia is now well established to partially reduce disability in term and near-term infants with moderate-severe hypoxic-ischemic encephalopathy. Preclinical and clinical studies have confirmed that current protocols for therapeutic hypothermia are near optimal. The challenge is now to identify complementary therapies that can further improve outcomes, in combination with therapeutic hypothermia. Overall, anti-excitatory and anti-apoptotic agents have shown variable or even no benefit in combination with hypothermia, suggesting overlapping mechanisms of neuroprotection. Inflammation appears to play a critical role in the pathogenesis of injury in the neonatal brain, and thus, there is potential for drugs with immunomodulatory properties that target inflammation to be used as a therapy in neonates. In this review, we examine the evidence for neuroprotection with immunomodulation after hypoxia-ischemia. For example, stem cell therapy can reduce inflammation, increase cell survival, and promote cell maturation and repair. There are also encouraging preclinical data from small animals suggesting that stem cell therapy can augment hypothermic neuroprotection. However, there is conflicting evidence, and rigorous testing in translational animal models is now needed. |
Databáze: | OpenAIRE |
Externí odkaz: |